Richard T. Ngomba

Località Camerelle, IS
Pozzilli, 86077, Italy

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 27 publications

Travel health needs and experiences of people living with Parkinson's disease and their carers: an exploratory qualitative study.

Travel health needs and experiences of people living with Parkinson's disease and their carers: an exploratory qualitative study.

Journal: Journal of travel medicine
Published: December 23, 2025

Soluble tau aggregates decrease the threshold for thalamic oscillations and increase the excitability of thalamic neurons.

Soluble tau aggregates decrease the threshold for thalamic oscillations and increase the excitability of thalamic neurons.

Journal: Neuropharmacology
Published: February 28, 2025

Epilepsy in rural South Africa: Patient experiences and healthcare challenges.

Epilepsy in rural South Africa: Patient experiences and healthcare challenges.

Journal: Epilepsia open
Published: February 16, 2024

The Metabotropic Glutamate 5 Receptor in Sleep and Wakefulness: Focus on the Cortico-Thalamo-Cortical Oscillations.

The Metabotropic Glutamate 5 Receptor in Sleep and Wakefulness: Focus on the Cortico-Thalamo-Cortical Oscillations.

Journal: Cells
Published: March 13, 2023

Oscillatory Deficits in the Sub-Chronic PCP Rat Model for Schizophrenia Are Reversed by mGlu5 Receptor-Positive Allosteric Modulators VU0409551 and VU0360172.

Oscillatory Deficits in the Sub-Chronic PCP Rat Model for Schizophrenia Are Reversed by mGlu5 Receptor-Positive Allosteric Modulators VU0409551 and VU0360172.

Journal: Cells
Published: February 07, 2023

Network analysis reveals a role of the hippocampus in absence seizures: The effects of a cannabinoid agonist.

Network analysis reveals a role of the hippocampus in absence seizures: The effects of a cannabinoid agonist.

Journal: Epilepsy research
Published: November 10, 2022

Adenosine is released during thalamic oscillations to provide negative feedback control.

Adenosine is released during thalamic oscillations to provide negative feedback control.

Journal: Neuropharmacology
Published: February 14, 2022

The comparative effects of mGlu5 receptor positive allosteric modulators VU0409551 and VU0360172 on cognitive deficits and signalling in the sub-chronic PCP rat model for schizophrenia.

The comparative effects of mGlu5 receptor positive allosteric modulators VU0409551 and VU0360172 on cognitive deficits and signalling in the sub-chronic PCP rat model for schizophrenia.

Journal: Neuropharmacology
Published: September 22, 2021

Group I metabotropic glutamate receptor-mediated long term depression is disrupted in the hippocampus of WAG/Rij rats modelling absence epilepsy.

Group I metabotropic glutamate receptor-mediated long term depression is disrupted in the hippocampus of WAG/Rij rats modelling absence epilepsy.

Journal: Neuropharmacology
Published: February 15, 2021

Pharmacological activation of mGlu5 receptors with the positive allosteric modulator VU0360172, modulates thalamic GABAergic transmission.

Pharmacological activation of mGlu5 receptors with the positive allosteric modulator VU0360172, modulates thalamic GABAergic transmission.

Journal: Neuropharmacology
Published: April 17, 2020

Targeting metabotropic glutamate receptors in the treatment of epilepsy: rationale and current status.

Targeting metabotropic glutamate receptors in the treatment of epilepsy: rationale and current status.

Journal: Expert opinion on therapeutic targets
Published: February 26, 2019

Genetic rescue of absence seizures.

Genetic rescue of absence seizures.

Journal: CNS neuroscience & therapeutics
Published: February 01, 2018
Showing 1-12 of 27

Last Updated: 09/26/2026